[1]马世河,惠普晟,龙漫.基于网络药理学及分子对接技术探究黄连解毒汤治疗脓毒症的分子机制[J].西部中医药,2024,37(02):54-58.[doi:10.12174/j.issn.2096-9600.2024.02.12]
　MA Shihe,HUI Pusheng,LONG Man.Molecular Mechanism of the Treatment of Sepsis with Huanglian Jiedu Decoction Based on Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2024,37(02):54-58.[doi:10.12174/j.issn.2096-9600.2024.02.12]
点击复制

基于网络药理学及分子对接技术探究黄连解毒汤治疗脓毒症的分子机制
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
37
期数:
2024年02期
页码:
54-58
栏目:
二次研究
出版日期:
2024-02-15

文章信息/Info

Title:
Molecular Mechanism of the Treatment of Sepsis with Huanglian Jiedu Decoction Based on Network Pharmacology and Molecular Docking
作者:
马世河1, 惠普晟2, 龙漫3
1.重庆市开州区人民医院，重庆 400000
2.重庆医科大学附属第一医院，重庆 400000
3.湖北中医药大学，湖北 武汉 430000
Author(s):
MA Shihe1, HUI Pusheng2, LONG Man3
1.The People's Hospital of Kaizhou District, Chongqing 400000, China
2.The First Affiliated Hospital of Chongqing Medical University, Chongqing 400000, China
3.Hubei University of Chinese Medicine, Wuhan 430000, China
关键词:
脓毒症; 黄连解毒汤; 网络药理; 分子机制; 免疫
Keywords:
sepsis; network pharmacology; molecular mechanism; immunity
分类号:
R826.3
DOI:
10.12174/j.issn.2096-9600.2024.02.12
文献标志码:
A
摘要:
目的采用网络药理学方法和生物信息学理论，挖掘黄连解毒汤有效成分，预测黄连解毒汤治疗脓毒症的作用机制，为中医治疗该病提供理论依据。 方法利用TCMSP等数据库平台筛选黄连解毒汤有效活性成分。在Gene Card、OMIM及Disgenet数据库中获得脓毒症相关基因，结合疾病靶点及药物活性成分绘制PPI网络，对关键靶点并进行GO、KEGG富集分析以及运用Autodock软件进行关键靶点分子对接研究。 结果通过检索共筛选出黄连解毒汤有效活性成分59个，在此基础上获得206个预测靶点及关键基因；根据基因本体（gene ontology，GO）分析及京都基因与基因组百科全书（Kyoto encyclopedia of genes and genomes，KEGG）结果可知，黄连解毒汤作用于该疾病主要涉及细胞因子活化、免疫和炎症相关过程激活等生物进程如肿瘤坏死因子（tumor necrosis factor，TNF）、白细胞介素17（interleukin-17，IL-17）炎症信号通路及晚期糖基化通路（AGEs-RAGE）等。分子对接结果表明药对的活性成分可以对核心靶点（JUN和TNF）发挥调控作用。 结论黄连解毒汤治疗脓毒症作用机制是多层次、多角度的，其主要机制集中在抗炎及氧化应，为研究黄连解毒汤多成分、多靶点治疗脓毒症网络关系提供了新的研究思路。
Abstract:
ObjectiveTo provide theoretical evidence for TCM therapy of sepsis by unearthing the active ingredients of Huanglian Jiedu Tang and predicting the mechanism of treating sepsis with the decoction with network pharmacology and bioinformatics. MethodsThe active ingredients of Huanglian Jiedu Tang were prepared by screening in TCMSP. Gene Card, OMIM and Disgenet databases were used to obtain sepsis-related genes, and PPI network was mapped by combining with disease targets and active ingredients of the drug, to carry out GO and KEGG enrichment analysis for key targets, and to conduct the study of molecular docking of key targets using Autodock software. ResultsThrough searching, there were 59 active ingredients of Huanglian Jiedu Tang, involving 206 predicted targets and key genes; the results of GO analysis and KEGG presented that the decoction acting on sepsis mainly referred to the biological processes such as the activation and immunity of cytokines, the activation of inflammation-related processes, including TNF, IL-17 and AGEs-RAGE. The results of molecular docking indicated that the active ingredients of the drug pairs could play the regulatory role in core targets (JUN and TNF). ConclusionHuanglian Jiedu Tang could treat sepsis from multi-level and multi-angle, and its main mechanism focuses on anti-inflammation and oxidative stress, which could provide new research thinking for the study on treating sepsis with the decoction from multi-component and multi-target.

相似文献/References:

[1]赵帅,李娟,季清娜,等.中西医结合治疗脓毒症胃肠功能障碍临床观察[J].西部中医药,2013,26(11):98.
　ZHAO Shuai,LI Juan,JI Qingna,et al.Clinical Observation on Treatment for Gastrointestinal Dysfunction of Sepsis with Integrative Medicine[J].Western Journal of Traditional Chinese Medicine,2013,26(02):98.
[2]张靓,赵雷,孙芳园,等.升降散治疗瘀毒内阻型脓毒症的临床研究[J].西部中医药,2017,30(12):45.
　ZHANG Liang,ZHAO Lei,SUN Fangyuan,et al.Clinical Study of ShengJiang Powder in the Treatment of Sepsis of Stasis-Toxin Internal Obstruction Pattern[J].Western Journal of Traditional Chinese Medicine,2017,30(02):45.
[3]王宜艳,陈伟.芪参合剂对耐药肺炎克雷伯菌脓毒症大鼠的固有免疫调节作用研究[J].西部中医药,2020,33(02):6.[doi:10.12174/j.issn.1004-6852.2020.02.02]
　WANG Yiyan,CHEN Wei.A Study on the Regulating Action of Qishen Mixture for Innate Immunityof Drug-resistant Pneumoniae Klebsiella Sepsis Rats[J].Western Journal of Traditional Chinese Medicine,2020,33(02):6.[doi:10.12174/j.issn.1004-6852.2020.02.02]
[4]浦清,刘蕾蕾,居培红,等.血必净注射液对脓毒症患者治疗效果及血清甲状腺激素水平的影响[J].西部中医药,2020,33(06):85.[doi:10.12174/j.issn.1004-6852.2020.06.22]
　PU Qing,LIU Leilei,JU Peihong,et al.Clinical Effects of Xuebijing Injection in Treating Sepsis and Its Impacts on the Levels of Serum Thyroid Hormone[J].Western Journal of Traditional Chinese Medicine,2020,33(02):85.[doi:10.12174/j.issn.1004-6852.2020.06.22]
[5]陈剑明,刘清泉,黄坡,等.中医通腑泄热法治疗脓毒症胃肠功能障碍的系统评价与Meta分析[J].西部中医药,2022,35(02):67.[doi:10.12174/j.issn.2096-9600.2022.02.17]
　CHEN Jianming,LIU Qingquan,HUANG Po,et al.Systematic Evaluation and Meta-analysis of TCM Bowel-freeing Method of TongFu XieRe in the Treatment of Gastrointestinal Dysfunction in Sepsis[J].Western Journal of Traditional Chinese Medicine,2022,35(02):67.[doi:10.12174/j.issn.2096-9600.2022.02.17]
[6]古惠文,江勉君,朱君瑶,等.基于网络药理学及分子对接分析川芎嗪治疗脓毒症的作用机制[J].西部中医药,2022,35(10):17.[doi:10.12174/j.issn.2096-9600.2022.10.05]
　GU Huiwen,JIANG Mianjun,ZHU Junyao,et al.The Mechanism of Treating Sepsis by Ligustrazine Based on Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2022,35(02):17.[doi:10.12174/j.issn.2096-9600.2022.10.05]
[7]江四华,代卓青,刘田,等.四逆汤通过自噬途径对脓毒症大鼠左心室功能的影响[J].西部中医药,2023,36(11):19.[doi:10.12174/j.issn.2096-9600.2023.11.04]
　JIANG Sihua,DAI Zhuoqing,LIU Tian,et al.Effects of Sini Tang on Left Ventricular Function in Sepsis Rats via Autophagy[J].Western Journal of Traditional Chinese Medicine,2023,36(02):19.[doi:10.12174/j.issn.2096-9600.2023.11.04]

备注/Memo

备注/Memo:
马世河（1984—），男，主治医师。研究方向：感染免疫性疾病的研究。国家自然科学基金青年基金（81803969）。
更新日期/Last Update: 2024-02-15